Chondrosarcoma

• 

  Subject Areas on Research

  • A thin-layer model for viscoelastic, stress-relaxation testing of cells using atomic force microscopy: do cell properties reflect metastatic potential? 
  • Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein. 
  • Anterior chest wall mass in an elderly male. 
  • Association between ratio of matrix metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. 
  • Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. 
  • Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. 
  • Chemical modification and site-directed mutagenesis of conserved HXXH and PP-loop motif arginines and histidines in the murine bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase. 
  • Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. 
  • Clear cell chondrosarcoma: Cytologic findings in six cases. 
  • Collagenase specificity in chondrosarcoma metastasis. 
  • Considerations in fractionated proton radiation therapy: clinical potential and results. 
  • Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. 
  • Expression of the intermediate filament peripherin in extraskeletal myxoid chondrosarcoma. 
  • Extraskeletal myxoid chondrosarcoma of the jugular foramen. 
  • Extraskeletal myxoid chondrosarcoma of the knee. 
  • Extraskeletal myxoid chondrosarcoma of the knee. 
  • Fine-needle aspiration cytology of articular and periarticular lesions. 
  • Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. 
  • Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth. 
  • Hormonal and metabolic regulation of human chondrosarcoma in vitro. 
  • Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. 
  • Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma. 
  • Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. 
  • Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research. 
  • NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. 
  • Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasia. 
  • Patched-one or smoothened gene mutations are infrequent in chondrosarcoma. 
  • Primary chondroid melanoma. 
  • Primary cilia attenuate hedgehog signalling in neoplastic chondrocytes. 
  • Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells. 
  • Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. 
  • The clinical management of chondrosarcoma. 
  • The clinical significance of tenascin-C splice variant expression in chondrosarcoma. 
  • Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes.